SECsense Logo

Kiniksa Pharmaceuticals 8-K Report: Key Financial Insights as of January 13, 2025

$KNSA
Form 8-K
Filed on: 2025-01-13
Source
Kiniksa Pharmaceuticals 8-K Report: Key Financial Insights as of January 13, 2025

The extracted key information from the provided financial report section is as follows:

  1. Entity Identification:
  • Company Name: Kiniksa Pharmaceuticals International, plc
  • CIK: 0001730430
  • IRS Employer Identification Number: 98-1795578
  • Address: 23 Old Bond Street, Floor 3, London W1S 4PZ, GB
  • Phone Number: 781-431-9100
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 13, 2025
  1. Stock Information:
  • Class of Shares: Class A Ordinary Shares
  • Nominal Value: $0.000273235
  • Stock Symbol: KNSA
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Date: January 13, 2025
  • The context specifies that the data is for a single day (startDate and endDate are the same).
  1. Measurement Units:
  • The financial data is reported in USD (United States Dollar).
  • Shares are also a unit of measurement in this context.

This information provides an overview of Kiniksa Pharmaceuticals, including its financial reporting date, share class details, and contact information, which could be relevant for investors and analysts assessing the company's performance and compliance.